McKinsey Advised Johnson and Johnson on Increasing Opioid Sales
1–10 of 160 posts
Re: McKinsey Advised Johnson and Johnson on Increasing Opioid Sales
#2""" McKinsey recommended “targeting and influencing” doctors who specifically treat back pain in the elderly and those in long-term care. The consultants also advised the company to move physicians who were “stuck” in prescribing less potent opioids into prescribing stronger formulations. """
Re: McKinsey Advised Johnson and Johnson on Increasing Opioid Sales
#3Re: McKinsey Advised Johnson and Johnson on Increasing Opioid Sales
#4The harm caused by any given medical advertisement is directly proportional to its effectiveness. Every pharmaceutical sales rep is an immoral cancer on our society.
Re: McKinsey Advised Johnson and Johnson on Increasing Opioid Sales
#5The marketing of medicine in inherently unethical because it seeks to override doctors and consumers information-based evaluations, and instead make a choice based on emotional propaganda. The harm caused by any given medical advertisement is directly proportional to its effectiveness. Every pharmaceutical sales rep is an immoral cancer on our society.
Re: McKinsey Advised Johnson and Johnson on Increasing Opioid Sales
#6The marketing of medicine in inherently unethical because it seeks to override doctors and consumers information-based evaluations, and instead make a choice based on emotional propaganda. The harm caused by any given medical advertisement is directly proportional to its effectiveness. Every pharmaceutical sales rep is an immoral cancer on our society.
How can we prove that this is false or that the benefits are smaller than the drawbacks?
Re: McKinsey Advised Johnson and Johnson on Increasing Opioid Sales
#7The marketing of medicine in inherently unethical because it seeks to override doctors and consumers information-based evaluations, and instead make a choice based on emotional propaganda. The harm caused by any given medical advertisement is directly proportional to its effectiveness. Every pharmaceutical sales rep is an immoral cancer on our society.
To play Devil's Advocate - without pharmaceutical companies developing and marketing drugs, how do we set up an incentive structure that encourages R&D and innovation?
Re: McKinsey Advised Johnson and Johnson on Increasing Opioid Sales
#8Re: McKinsey Advised Johnson and Johnson on Increasing Opioid Sales
#9The marketing of medicine in inherently unethical because it seeks to override doctors and consumers information-based evaluations, and instead make a choice based on emotional propaganda. The harm caused by any given medical advertisement is directly proportional to its effectiveness. Every pharmaceutical sales rep is an immoral cancer on our society.
To play Devil's Advocate - without pharmaceutical companies developing and marketing drugs, how do we set up an incentive structure that encourages R&D and innovation?
Re: McKinsey Advised Johnson and Johnson on Increasing Opioid Sales
#10The marketing of medicine in inherently unethical because it seeks to override doctors and consumers information-based evaluations, and instead make a choice based on emotional propaganda. The harm caused by any given medical advertisement is directly proportional to its effectiveness. Every pharmaceutical sales rep is an immoral cancer on our society.
To play Devil's Advocate - without pharmaceutical companies developing and marketing drugs, how do we set up an incentive structure that encourages R&D and innovation?